Structural brain abnormalities in individuals with an at-risk mental state who later develop psychosis
Stefan Borgwardt(Social Neuroscience Lab), Anita Riecher‐Rössler(University Hospital of Basel), Paola Dazzan(King's College London), Gregor Berger(University Hospital of Zurich), Marcus D’Souza(University Hospital of Basel), Ute Gschwandtner(University Hospital of Basel), Ernst‐Wilhelm Radue, Jacqueline Aston(University Hospital of Basel), Philip McGuire(Warneford Hospital), Marlon Pflüger(University Hospital of Basel)
Cited by 150
Related Papers
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
|The Lancet|2008|1.1k
Evaluation of Patients Treated with Natalizumab for Progressive Multifocal Leukoencephalopathy
|New England Journal of Medicine|2006|792
Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment
|Molecular Psychiatry|2023|684